Renaissance Technologies’s Zomedica Corp. ZOM Stock Holding History

Renaissance Technologies’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,120,642	Closed	-$494K	–	3984
2024 Q4	$494K	Buy	+4,120,642	New	+$519K	﹤0.01%	2850
2023 Q3	–	Sell	-58,822	Closed	-$12K	–	4324
2023 Q2	$12K	Buy	+58,822	New	+$11.9K	﹤0.01%	3822
2023 Q1	–	Sell	-126,000	Closed	-$21K	–	4591
2022 Q4	$21K	Sell	126,000 -889,500	-88%	-$182K	﹤0.01%	3957
2022 Q3	$214K	Sell	1,015,500 -1,492,000	-60%	-$395K	﹤0.01%	3355
2022 Q2	$552K	Buy	+2,507,500	New	+$638K	﹤0.01%	3107
2021 Q3	–	Sell	-13,371,960	Closed	-$11.1M	–	4051
2021 Q2	$11.1M	Buy	+13,371,960	New	+$12.5M	0.01%	1100
2019 Q4	–	Sell	-36,220	Closed	-$13K	–	3834
2019 Q3	$13K	Buy	+36,220	New	+$11.2K	﹤0.01%	3388

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Renaissance Technologies's ZOM Position: Q1 2025 in Review

Renaissance Technologies sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 4,120,642 shares — an estimated $494K sold.

Renaissance Technologies first reported a position in ZOM in Q3 2019 and held it in 7 quarters. The position peaked at $11.1M in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

Renaissance Technologies reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
Renaissance Technologies sold 4,120,642 Zomedica Corp. shares in Q1 2025, an estimated $494K.
Renaissance Technologies first reported a position in Zomedica Corp. in Q3 2019 and held it in 7 quarters.
Renaissance Technologies's Zomedica Corp. position peaked at $11.1M in Q2 2021.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.